ÂÜÀòÂÒÂ×

Negin Mokhtari is a seasoned professional in the fields of biotechnology and cancer research, currently serving as a Partner at Bioluminescence Ventures and as a Board Observer for multiple companies, including Nido Biosciences, Aqtual, Inc., General Inception, and Redux. Mokhtari previously held the position of Senior Associate at Genoa Ventures, focusing on early-stage investments in biology and technology. Experience includes program management in business and commercialization at Freenome, where the focus was on developing blood tests for early cancer detection, and conducting research as a Scientist at the OHSU Knight Cancer Institute, specializing in precision medicine and drug delivery. Mokhtari's educational background includes a Ph.D. in Nanoscale Devices and Systems from UC San Diego and a Bachelor's degree in Electrical and Electronics Engineering from the University of Minnesota.